Coherus BioSciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:CHRS Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
23 May 25	SellUS$73,881	Mats Wahlstrom	Individual		99,988	US$0.74

Insider Trading Volume

Insider Buying: CHRS insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of CHRS?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	20,000	0.0173%
Individual Insiders	5,021,092	4.33%
General Public	47,815,631	41.2%
Institutions	63,076,553	54.4%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 52.94% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.62%	The Vanguard Group, Inc.	11,151,905	US$8.7m	-0.02%	no data
9.47%	BlackRock, Inc.	10,978,359	US$8.6m	-0.88%	no data
4.54%	Rubric Capital Management LP	5,258,754	US$4.1m	0%	0.07%
4.4%	Tang Capital Management, LLC	5,097,362	US$4.0m	39.7%	0.2%
2.76%	Thomas Satterfield	3,204,514	US$2.5m	0%	no data
2.62%	KKR & Co. Inc.	3,036,576	US$2.4m	0.02%	0.01%
2.5%	Millennium Management LLC	2,899,952	US$2.3m	176%	no data
2.29%	Geode Capital Management, LLC	2,655,500	US$2.1m	2.15%	no data
1.92%	State Street Global Advisors, Inc.	2,226,851	US$1.7m	2.29%	no data
1.9%	CM Management, LLC	2,200,000	US$1.7m	2.44%	1.8%
1.66%	C WorldWide Asset Management Fondsmaeglerselskab A/S	1,928,464	US$1.5m	0%	0.01%
0.96%	Dennis Lanfear	1,117,758	US$870.7k	0%	no data
0.88%	Citigroup Inc.,Banking and Securities Investments	1,021,881	US$796.0k	113%	no data
0.86%	Los Angeles Capital Management LLC	991,513	US$772.4k	-11.2%	no data
0.82%	Charles Schwab Investment Management, Inc.	950,676	US$740.6k	-2.68%	no data
0.82%	Northern Trust Global Investments	947,124	US$737.8k	-5.9%	no data
0.78%	Macquarie Investment Management Business Trust	899,999	US$701.1k	0%	no data
0.72%	Hudson Bay Capital Management LP	835,000	US$650.5k	0%	no data
0.64%	SEI Investments Management Corporation	742,827	US$578.7k	-18.2%	no data
0.59%	Tejara Capital Limited., Asset Management Arm	687,218	US$535.3k	-6.9%	0.28%
0.57%	AQR Capital Management, LLC	656,441	US$511.4k	-45.6%	no data
0.54%	Stonepine Capital Management LLC	620,588	US$483.4k	148%	0.25%
0.44%	Renaissance Technologies LLC	510,628	US$397.8k	0%	no data
0.34%	BNY Asset Management	389,121	US$303.1k	-0.48%	no data
0.32%	UBS Asset Management AG	368,951	US$287.4k	-48%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/06/02 05:42
End of Day Share Price	2025/06/02 00:00
Earnings	2025/03/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Coherus BioSciences, Inc. is covered by 15 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Colleen Kusy	Baird
Balaji Prasad	Barclays
Balaji Prasad	Barclays